Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.01% |
| 2 | Technology | 7.75% |
| 3 | Financials | 7.01% |
| 4 | Consumer Discretionary | 6.9% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Celanese
CE
$5.14B
| $36.1M | 0.05% |
418,022
+297,128
| +246% | +$24.8M |
|
427
PUT
IBM
IBM
$222B
| $36M | 0.05% |
311,499
+71,024
| +30% | +$8.25M |
|
428
Acuity Brands
AYI
$10.3B
| $35.8M | 0.05% |
373,743
+264,675
| +243% | +$23.3M |
|
429
PUT
Starbucks
SBUX
$122B
| $35.8M | 0.05% |
486,000
-209,800
| -30% | -$15.8M |
|
430
Cirrus Logic
CRUS
$5.78B
| $35.7M | 0.05% |
577,148
+448,977
| +350% | +$30.7M |
|
|
IPOC.U
431
DELISTED
Social Capital Hedosophia Holdings Corp. III Units, each consisting of one Class A ordinary share an
IPOC.U
| $35.6M | 0.05% |
+3,000,001
| New | +$32.1M |
|
432
Norwegian Cruise Line
NCLH
$7.92B
| $35.6M | 0.05% |
+2,167,101
| New | +$31.8M |
|
433
Ameriprise Financial
AMP
$49.1B
| $35.6M | 0.05% |
236,982
+194,130
| +453% | +$24.9M |
|
434
Omnicom Group
OMC
$24B
| $35.5M | 0.05% |
649,452
+426,496
| +191% | +$23.2M |
|
435
Eli Lilly
LLY
$1.12T
| $35.4M | 0.05% |
215,915
+196,369
| +1,005% | +$30.1M |
|
436
VICI Properties
VICI
$29.2B
| $35.4M | 0.05% |
1,753,181
+1,716,798
| +4,719% | +$31.4M |
|
437
iShares MBS ETF
MBB
$39B
| $35.4M | 0.05% |
319,590
+314,875
| +6,678% | +$34.9M |
|
438
UDR
UDR
$12.1B
| $35.3M | 0.05% |
943,123
-82,728
| -8% | -$3.09M |
|
439
Northern Trust
NTRS
$33.6B
| $35.2M | 0.05% |
443,694
+214,925
| +94% | +$17M |
|
440
Moderna
MRNA
$57.9B
| $35.2M | 0.05% |
547,977
-68,434
| -11% | -$3.75M |
|
441
AES
AES
$10.5B
| $35.2M | 0.05% |
2,427,947
+1,285,451
| +113% | +$16.9M |
|
|
APLS
442
DELISTED
Apellis Pharmaceuticals
APLS
| $35.1M | 0.05% |
1,075,250
-282,336
| -21% | -$9.07M |
|
443
Royalty Pharma
RPRX
$27.3B
| $35M | 0.05% |
+721,802
| New | +$35.7M |
|
444
PUT
AbbVie
ABBV
$468B
| $34.9M | 0.05% |
355,200
-673,900
| -65% | -$59.3M |
|
445
Marriott International
MAR
$92.9B
| $34.8M | 0.05% |
406,477
-82,247
| -17% | -$7.14M |
|
446
Thermo Fisher Scientific
TMO
$233B
| $34.8M | 0.05% |
96,131
+82,996
| +632% | +$27.8M |
|
|
ATVI
447
PUT
DELISTED
Activision Blizzard
ATVI
| $34.6M | 0.05% |
456,200
-297,900
| -40% | -$20.8M |
|
448
Axalta
AXTA
$7.75B
| $34.6M | 0.05% |
1,533,971
+378,941
| +33% | +$7.75M |
|
449
Freeport-McMoran
FCX
$110B
| $34.6M | 0.05% |
2,988,802
+1,306,397
| +78% | +$12M |
|
450
Plug Power
PLUG
$3.17B
| $34.5M | 0.05% |
4,202,917
+3,101,576
| +282% | +$14.5M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.